Filing Flows › Iradimed (IRMD) › Operating margin
Iradimed (IRMD) operating margin by quarter
Iradimed's operating margin was 33.6% in Q3 2026 (third quarter 2026), +2.4 pts from Q2 2026. Over the last 7 quarters it ranged from 27.8% (Q1 2025) to 33.6% (Q3 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 33.6% | +2.4 pts | +1.4 pts |
| Q2 2026 | 31.2% | -1.7 pts | -2.0 pts |
| Q1 2026 | 32.9% | +1.7 pts | +5.1 pts |
| Q4 2025 | 31.3% | -1.0 pts | — |
| Q3 2025 | 32.2% | -1.0 pts | — |
| Q2 2025 | 33.3% | +5.4 pts | — |
| Q1 2025 | 27.8% | — | — |
Q3 2026 at a glance
Iradimed, Q3 2026: revenue $24.2M (+14% year over year), operating margin 33.6%, net earnings $6.5M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Iradimed's operating margin?
Iradimed's operating margin was 33.6% in Q3 2026 (third quarter 2026), +2.4 pts from Q2 2026.
How has Iradimed's operating margin changed?
Over the last 7 quarters it ranged from 27.8% (Q1 2025) to 33.6% (Q3 2026).